S. Maggio

发表

The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells

D. Paik, S. Payne, S. Spiegel, 2004, Cancer Research.

Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation

Jorge A. Almenara, S. Grant, R. Rosato, 2004, Leukemia.

Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions

Jorge A. Almenara, P. Atadja, P. Dent, 2008, Molecular Cancer Therapeutics.

Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions

Jorge A. Almenara, P. Dent, S. Grant, 2007, Molecular Cancer Therapeutics.

Protein Kinase C-dependent Activation of the Tumor Necrosis Factor Receptor-mediated Extrinsic Cell Death Pathway Underlies Enhanced Apoptosis in Human Myeloid Leukemia Cells Exposed to Bryostatin 1 and Flavopiridol1

P. Dent, S. Grant, L. Cartee, 2003 .

Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridol.

P. Dent, S. Grant, L. Cartee, 2003, Molecular cancer therapeutics.

Protein Kinase C-dependent Activation of the Tumor Necrosis Factor Receptor-mediated Extrinsic Cell Death Pathway Underlies Enhanced Apoptosis in Human Myeloid Leukemia Cells Exposed to Bryostatin 1 and Flavopiridol 1

P. Dent, S. Grant, L. Cartee, 2003 .

The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide.

P. Atadja, S. Payne, S. Spiegel, 2006, Molecular pharmacology.

Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells

P. Atadja, P. Dent, S. Grant, 2005, Molecular Cancer Therapeutics.

7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.

P. Dent, P. Lin, S. Grant, 2002, International journal of oncology.